Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study
about
A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer.Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions.Metastatic and triple-negative breast cancer: challenges and treatment options
P2860
Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Correlation of baseline biomar ...... er: An OCOG ZAMBONEY sub-study
@ast
Correlation of baseline biomar ...... er: An OCOG ZAMBONEY sub-study
@en
type
label
Correlation of baseline biomar ...... er: An OCOG ZAMBONEY sub-study
@ast
Correlation of baseline biomar ...... er: An OCOG ZAMBONEY sub-study
@en
prefLabel
Correlation of baseline biomar ...... er: An OCOG ZAMBONEY sub-study
@ast
Correlation of baseline biomar ...... er: An OCOG ZAMBONEY sub-study
@en
P2093
P2860
P1476
Correlation of baseline biomar ...... er: An OCOG ZAMBONEY sub-study
@en
P2093
Brandy Cochrane
Christina L Addison
Gregory R Pond
Huijun Zhao
Mark Clemons
Mark N Levine
Stephen K Chia
P2860
P356
10.1016/J.JBO.2015.04.001
P577
2015-06-12T00:00:00Z